Please use this identifier to cite or link to this item:
Title: Comparison of pharmacokinetics and pharmacodynamics of adrenoceptor agonists and antagonists as antihypertensive agents.
Austin Authors: Louis, William J ;McNeil, John J;Anavekar, S N;Conway, Elizabeth L;Workman, B;Howes, L G;Drummer, Olaf H;Jarrott, B
Affiliation: Department of Clinical Pharmacology, Austin Hospital, Heidelberg, Victoria, Australia
Issue Date: 16-May-1987
Publication information: Journal of Cardiovascular Pharmacology; 10 Suppl 12(): S100-3
Abstract: Central and peripheral alpha-adrenoceptors play an important role in cardiovascular regulation, and selective alpha 1-adrenoceptor antagonists and alpha 2-adrenoceptor agonists have an established place in the therapy of hypertension. Prazosin is a selective alpha 1-antagonist that is both effective in lowering blood pressure and well tolerated. However, the more recently developed alpha 1-antagonists doxazosin and terazosin offer the advantage of having longer half-lives, allowing once daily administration. Clonidine is a centrally acting alpha 2-agonist whose clinical use has often been limited by the dose dependent side effects of dry mouth and sedation, and the belief that it should be given three times per day. However, recent studies have shown that it has substantial antihypertensive efficacy with minimal side effects at low doses, and that half-life is long enough to allow twice daily administration. An improved understanding of the pharmacodynamics and pharmacokinetics of drugs acting on alpha-adrenoceptors allows a more rational approach to their clinical application.
Gov't Doc #: 2455158
Type: Journal Article
Subjects: Adrenergic alpha-Agonists.pharmacokinetics.therapeutic use
Adrenergic alpha-Antagonists.pharmacokinetics.therapeutic use
Blood Pressure
Clonidine.adverse effects.pharmacokinetics.therapeutic use
Hypertension.drug therapy.physiopathology
Prazosin.analogs & derivatives.pharmacokinetics.therapeutic use
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Nov 27, 2022

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.